• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A clinical and pathological study of fatal cases of status asthmaticus.

作者信息

HOUSTON J C, DE NAVASQUEZ S, TROUNCE J R

出版信息

Thorax. 1953 Sep;8(3):207-13. doi: 10.1136/thx.8.3.207.

DOI:10.1136/thx.8.3.207
PMID:13102418
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1019266/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d451/1019266/8ac85c900728/thorax00031-0046-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d451/1019266/847161a7841b/thorax00031-0045-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d451/1019266/163ea56d1377/thorax00031-0045-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d451/1019266/d26306f33439/thorax00031-0045-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d451/1019266/fb36ffe64e1e/thorax00031-0046-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d451/1019266/d7f363bba29c/thorax00031-0046-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d451/1019266/8ac85c900728/thorax00031-0046-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d451/1019266/847161a7841b/thorax00031-0045-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d451/1019266/163ea56d1377/thorax00031-0045-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d451/1019266/d26306f33439/thorax00031-0045-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d451/1019266/fb36ffe64e1e/thorax00031-0046-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d451/1019266/d7f363bba29c/thorax00031-0046-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d451/1019266/8ac85c900728/thorax00031-0046-c.jpg

相似文献

1
A clinical and pathological study of fatal cases of status asthmaticus.哮喘持续状态致死病例的临床与病理研究
Thorax. 1953 Sep;8(3):207-13. doi: 10.1136/thx.8.3.207.
2
[APROPOS OF 2 FATAL CASES OF STATUS ASTHMATICUS].[关于两例哮喘持续状态致死病例]
Srp Arh Celok Lek. 1964 May;92:573-7.
3
Status asthmaticus, severe acute asthma or severe exacerbation of asthma.哮喘持续状态、严重急性哮喘或哮喘严重加重。
Allergol Immunopathol (Madr). 1985 Sep-Oct;13(5):435-7.
4
[Characteristics of the clinical course and therapy of status asthmaticus].
Ter Arkh. 1985;57(5):28-31.
5
Medications and Recent Patents for Status Asthmaticus in Children.儿童重度哮喘的药物治疗与近期专利
Recent Pat Inflamm Allergy Drug Discov. 2017;11(1):12-21. doi: 10.2174/1872213X11666170130143524.
6
[Analysis of deaths during the course of status asthmaticus in patients treated at the Acute Asthma Center in the Pneumonology Clinic of the Warsaw Medical School in the years 1991-1996].[1991年至1996年华沙医学院肺病诊所急性哮喘中心治疗的哮喘持续状态患者死亡情况分析]
Pneumonol Alergol Pol. 1998;66(3-4):141-7.
7
[Causes of status asthmaticus and fatal outcome in patients with bronchial asthma].[支气管哮喘患者哮喘持续状态的病因及致命结局]
Klin Med (Mosk). 1988 Mar;66(3):61-6.
8
The management of severe intractable asthma (status asthmaticus).重度难治性哮喘（哮喘持续状态）的管理
Med Clin North Am. 1949 Nov;33:1597-1603. doi: 10.1016/s0025-7125(16)35490-6.
9
Spontaneous fracture of the first rib as a complication of status asthmaticus.自发性第一肋骨骨折作为哮喘持续状态的一种并发症。
Ann Allergy. 1947 Sep-Oct;5(5):488.
10
Physiologic therapy of intractable bronchial asthma and status asthmaticus.难治性支气管哮喘和哮喘持续状态的生理治疗
Am Pract Dig Treat. 1948 Jul;2(11):703-12.

引用本文的文献

1
Critical Care Management of Severe Asthma Exacerbations.重度哮喘急性发作的重症监护管理
J Clin Med. 2024 Feb 1;13(3):859. doi: 10.3390/jcm13030859.
2
Endotracheal Tube Size Is Associated With Mortality in Patients With Status Asthmaticus.经气管插管的大小与哮喘持续状态患者的死亡率相关。
Respir Care. 2022 Mar;67(3):283-290. doi: 10.4187/respcare.09609.
3
Predicting treatment outcomes following an exacerbation of airways disease.预测气道疾病加重后的治疗结果。

本文引用的文献

1
A clinicopathologic study of bronchial asthma with consideration of its relationship to the "general adaptation syndrome".一项关于支气管哮喘的临床病理研究，并探讨其与“一般适应综合征”的关系。
Ann Intern Med. 1950 Jul;33(1):134-62. doi: 10.7326/0003-4819-33-1-134.
2
Correlation of clinical and autopsy findings in 176 cases of asthma.176例哮喘患者临床与尸检结果的相关性
J Allergy. 1952 May;23(3):193-203. doi: 10.1016/0021-8707(52)90017-8.
3
Sudden death from asthma.哮喘猝死
PLoS One. 2021 Aug 20;16(8):e0254425. doi: 10.1371/journal.pone.0254425. eCollection 2021.
4
Acute or chronic pulmonary emphysema? Or both?-A contribution to the diagnosis of death due to violent asphyxiation in cases with pre-existing chronic emphysema.急性或慢性肺气肿？还是两者都有？——对既有慢性肺气肿的暴力窒息死亡案例的死因诊断的一点贡献。
Int J Legal Med. 2022 Jan;136(1):133-147. doi: 10.1007/s00414-021-02619-7. Epub 2021 Jun 28.
5
Molecular Targets for Biological Therapies of Severe Asthma.重度哮喘的生物治疗的分子靶点。
Front Immunol. 2020 Nov 30;11:603312. doi: 10.3389/fimmu.2020.603312. eCollection 2020.
6
Interleukin-5 in the Pathophysiology of Severe Asthma.白细胞介素-5在重度哮喘病理生理学中的作用
Front Physiol. 2019 Dec 17;10:1514. doi: 10.3389/fphys.2019.01514. eCollection 2019.
7
Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.重度嗜酸性粒细胞性哮喘：从白细胞介素-5的致病作用到美泊利珠单抗的治疗作用
Drug Des Devel Ther. 2017 Oct 30;11:3137-3144. doi: 10.2147/DDDT.S150656. eCollection 2017.
8
Interleukin-13 in Asthma and Other Eosinophilic Disorders.哮喘及其他嗜酸性粒细胞疾病中的白细胞介素-13
Front Med (Lausanne). 2017 Sep 19;4:139. doi: 10.3389/fmed.2017.00139. eCollection 2017.
9
Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma.美泊利珠单抗在重度嗜酸性粒细胞性哮喘中的患者概况及临床应用
Biologics. 2017 Jun 27;11:81-95. doi: 10.2147/BTT.S93954. eCollection 2017.
10
Update on reslizumab for eosinophilic asthma.瑞利珠单抗治疗嗜酸性粒细胞性哮喘的最新进展。
Expert Opin Biol Ther. 2015;15(10):1531-9. doi: 10.1517/14712598.2015.1090972.
Can Med Assoc J. 1951 Feb;64(2):95-102.